Ameliorative effect of conjugated silver nanoparticles against chromium-induced hepatotoxicity and renal toxicity in mice.

Hexavalent chromium induces oxidative stress in the liver and kidney. Therefore an study was designed to investigate the modulatory effect of biosynthesized AgNP against Cr (VI) induced hepatotoxicity and nephrotoxicity. The organs index, serum level of ALT, AST, ALP, MDA, total protein and creatinine were measured. The histopathology and micrometry of the liver and kidney were examined. The liver index was significantly increased (0.098 ± 0.13 g) with slight increase in kidney index in Cr exposed group. The serum level of ALT (163.0 ± 5.5 U/L), AST (484.0 ± 10.7 U/L), ALP (337.6 ± 9.6 U/L), MDA (641.2 ± 29.2 U/L), and creatinine (2.9 ± 0.2 mg/dL) were significantly increased ( ≤ 0.05) with significant decrease in total protein level (2.9 ± 0.2 g/dL) ( ≤ 0.05) in chromium treated group. In histopathology, distorted hepatic cords, necrosis, damaged glomerulus and Bowman's capsule were observed. Micrometric studies of the liver and kidney showed significant increase in size of hepatocytes (1188.2 ± 467.7 µ) and their nuclei (456.4 ± 206.7 µ), ACSA of Bowman's capsule (11835.5 ± 336.7 µ) and glomerulus (9051.8 ± 249.8 µ in Cr (VI) treated group. The size of brush border (10.1 ± 3.0 µ) was significantly reduced in Cr (VI) treated group however the ACSA of lumen was not significantly changed. With the administration of NSSE and AgNPs, decreased the oxidative damage caused by Cr (V).